Literature DB >> 29171778

Effect of matrix composition, sphere size and hormone concentration on diffusion coefficient of insulin for controlled gastrointestinal delivery for diabetes treatment.

Fernando Villaverde Cendon1, Regina Maria Matos Jorge1, Regina Weinschutz1, Alvaro Luiz Mathias1.   

Abstract

Oral insulin administration is limited due to its degradation by proteases. The hormone was encapsulated in spheres made of either pure calcium alginate (ALG) or its association with whey protein isolate (WPI-ALG) in order to minimise loss in the stomach region while allowing liberation in the maximum absorption area, located in the intestine. Diffusion coefficients for both matrix compositions were determined in vitro for gastric pH (5.88 and 10.26 × 10-12 m2 s-1) and intestinal pH (21.11 and 79.29 × 10-12 m2 s-1). Higher initial insulin concentrations and lower diameters accelerated its release, confirming Fickian behaviour. The analytic model exhibited a good fit in most cases. Computer simulations revealed that ALG spheres are more convenient for oral administration because they release more insulin in the intestine than the WPI-ALG ones, thus supporting its therapeutic viability for the purpose of reducing stress in those who depend on insulin.

Entities:  

Keywords:  Alginate; diffusion; gastrointestinal; insulin; oral administration; whey protein

Mesh:

Substances:

Year:  2017        PMID: 29171778     DOI: 10.1080/02652048.2017.1409820

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  1 in total

1.  Photoacoustic imaging reveals mechanisms of rapid-acting insulin formulations dynamics at the injection site.

Authors:  Anjul Khadria; Chad D Paavola; Konstantin Maslov; Francisco A Valenzuela; Andrea E Sperry; Amy L Cox; Rui Cao; Junhui Shi; Patricia L Brown-Augsburger; Emmanuel Lozano; Ross L Blankenship; Ranajoy Majumdar; Scott A Bradley; John M Beals; Sunday S Oladipupo; Lihong V Wang
Journal:  Mol Metab       Date:  2022-06-04       Impact factor: 8.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.